My research journey has focused on enablement of therapeutic discovery and development from structural biology to biophysical analysis to transgenic and behavioral animal models. I have over 18 years of experience in the life sciences, culminating in the foundation of Azor Biotek.

Bioinformatician by training with Postdoctoral studies in Cheminformatics, Drug Design and Quantum Mechanics with good experience in insilico and AI based CROs with diverse clients. Can be an active team player as well as can lead team.

Received Innocentive awards (USA) for chemical Innovations

As a medicinal chemist with postdoctoral experience in CADD, I've spent over 20 years advancing AI-driven methods for virtual screening. I'm a recognized leader in receptor-based VS.

Drug discovery and development scientist with a proven ability to successfully lead multi-disciplinary teams to achieve high quality results with a specialization in drug discovery, medicinal chemistry, CMC, and IND enabling studies

Organic chemist with 30+ years in crop protection at three organizations. Background in statistical experimental design, cheminformatics and property predictions. Contributed to the development of machine-learning based models whose application to compound acquisition improved high-throughput screening hit-rates.

Organic Chemist by training with 26 years managing drug discovery projects resulting 14 compounds entering clinical trials.

Cresset Discovery has a proven track record delivering high impact drug discovery projects. Their expert CADD scientists are the best at what they do and work alongside you from the ground up.  They apply the best in silico techniques and give expert advice and guidance, to accelerate your assets through the pipeline.

With a Bsc in chemistry and a PhD in computational chemistry, I have been offering services to the pharma industry for 20 years. I have led over 200 international scientific projects for over 30 international clients, in the areas of drug design and data mining for business development.

An experienced medicinal chemist and project leader with a record of delivering advanced leads and clinical candidates. Extensive expertise ranging from target selection to HTS triage/lead ID, to preclinical and clinical candidate nomination. >20 years’ experience managing internal and external drug discovery teams.

Bioorganic chemist by training with 30+ years experience in big and small pharma. Expertise in drug discovery including both FBLD and DEL, cheminfomatics, new technology development, library design and medicinal chemistry from screen to clinic.

A cell/molecular biologist, I have advanced drug discovery from target identification to clinical candidate selection over the past 25+ years.  Experience includes small molecule and biologics discovery, from hit ID, developing critical path assays, & optimizing lead molecules for advancement to the clinic.

Molecular Forecaster has brought together its world-class CADD tools with a multidisciplinary team to widely address challenges encountered in early-stage drug discovery. We aim to support as many small molecule projects as possible. Growing since 2019, MFI was created out of 15 years of research at McGill University.

Trained as a chemist, with postdoctoral training in biophysics and structural biology, I have a 19+ years track-record in industry leading project teams, phenotypic screening, target deconvolution, protein and oligonucleotide biophysics, and statistical design of experiment (DoE) for assay development.

An achievement-oriented professional with experience in R&D including new drug discovery, medicinal  chemistry and patent drafting. Actively involved in various antimicrobial and oncology projects starting from target selection to hit identification, hit to lead development, preclinical till clinical stage.

Computational chemist by training, with postdoctoral studies in structure-based drug discovery using HPC, who later spent 12+years at Astellas Pharma Inc. Experienced project leader in Astellas Pharma at MELLODDY consortium.

Company of one computational and three medicinal chemists who spent 10 years together in big pharma and have been consulting for small pharma since 2011.

Molecular biologist with over 30+ years in all aspects of early Drug Discovery. Working in Large Pharma and small Biotechs; identified 15 compounds for development, 4 novel drugs approved. Extensive experience with drug discovery CROs.

Organic chemist with long experience in drug discovery and development. Spent 20+ years in the big pharma world (Sanofi Ltd.). Experienced group leader, contributed to 5+ new drug developments. Honorary professor from the Technical University of Budapest.

Experienced leader of drug discovery projects from target ID to IND in large pharma.  In addition developed services for profiling kinases, ion channels and cellular readouts. Gained good working knowledge of PROTACs.

Translational biologist with 20+ of experience in big pharma and biotech. Experienced leader of drug discovery programs from target identification to early clinical studies.

Successful researcher with track record of progressing discovery projects by applying computational modeling methods, as supported by patent applications. Recognized for excellence, integrity, proactivity, and commitment to manage team, projects & resources, along with entrepreneurial and leadership skills.

Consultant Computational Chemist (10+ years). Previously organic chemist, then 20 years molecular modeller in early pharma research. Section Head in silico Drug Design.